Curebase is a startup based in the United States, most recent round Series B, 2 tracked investors.
Based in the United States, Curebase is a startup. Its most recent tracked round is Series B. Brouky records 2 investors associated with the company.
Curebase is an AI-powered eClinical platform designed to accelerate clinical trials by providing end-to-end solutions for sponsors, sites, and participants.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.